USNA Stock Recent News

Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two companies is the best option for those looking for undervalued stocks?

USANA Health Sciences (USNA) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.95 per share a year ago.

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2024 results will be released after the close of market on Tuesday, April 30, 2024. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and instit.

USANA Health Sciences, Inc. (USNA) Q4 2023 Earnings Call Transcript

USANA Health Sciences (USNA) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.66 per share a year ago.

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter and fiscal year 2023 results will be released after the close of market on Tuesday, February 6, 2024. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with.

USANA Health Sciences (USNA) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.78 per share a year ago.

Usana Health Sciences Inc.'s stock USNA, +1.59% fell 2% before turning flat in after-hours trade Tuesday, after the maker of nutritional supplements missed earnings estimates for the third quarter. Salt Lake City, Utah-based Usana posted net income of $11.3 million, or 59 cents a share, for the quarter, down from $14.9 million, or 78 cents a share, in the year-earlier period.

USANA Health Sciences has a diversified international presence, with 90% of net sales coming from international markets. The company has a healthy balance sheet with strong liquidity and solid asset/liability ratio. The launch of new digital tools and affiliate programs in 2023 is expected to drive net sales growth in the coming years.

Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks is more attractive to value investors?